Loading organizations...
§ Private Profile · Sandyford, Dublin, Ireland
Medical technology company developing, manufacturing, and marketing breast implants for aesthetic and reconstructive surgery.
GC Aesthetics is a Dublin, Ireland-based medical technology company that develops, manufactures, and markets proprietary aesthetic and reconstructive products, primarily focusing on breast implants for augmentation and reconstruction surgeries. The privately held enterprise utilizes a vertically integrated business strategy to produce medical devices backed by ten-year clinical data. Operating globally across more than 70 countries, the organization manufactures over 325,000 implants annually under its established Nagor and Eurosilicone brands. To date, the business has sold more than three million implants to surgeons and healthcare facilities worldwide, recently expanding its commercial footprint in international markets like Brazil. GC Aesthetics has raised approximately $60 million in total funding, including a $20 million Series D round, securing capital from institutional investors including Montreux Equity Partners, Oyster Capital, and Barry’s Tea Holdings. The medical technology company was established in 2007.
GC Aesthetics has raised $90.0M across 3 funding rounds.
GC Aesthetics has raised $90.0M in total across 3 funding rounds.
GC Aesthetics has raised $90.0M across 3 funding rounds. Most recently, it raised $20.0M Series D in July 2016.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 12, 2016 | $20M Series D | — | Barry's TEA Holdings, Montreux Equity Partners, Oyster Capital | Announced |
| Feb 21, 2014 | $40M Venture Round | — | Daniel Turner, OrbiMed, Oyster Capital | Announced |
| Oct 11, 2010 | $30M Venture Round | Howard Palefsky | — | Announced |
GC Aesthetics has raised $90.0M in total across 3 funding rounds.
GC Aesthetics's investors include Barry's Tea Holdings, Montreux Equity Partners, Oyster Capital, Daniel Turner, OrbiMed, Howard Palefsky.